India’s pharmaceutical industry is grappling with a severe raw material crisis, putting immense pressure on API producers. Prices of key chemicals and Active Pharmaceutical Ingredients (APIs) have skyrocketed, forcing manufacturers to cut production
Apollo Hospitals today announced a structured patient transfer initiative aimed at improving access to advanced critical care through coordinated air medical transportation across India and international regions.
Alembic Pharmaceuticals Limited has secured USFDA approval for Paroxetine Extended-Release Tablets USP 12.5 mg, marking another step forward in its growing U.S. generics portfolio.
Lupin Limited has received a USFDA tentative approval for daytime sleepiness drug, strengthening its position in the US generics market.
Government of India is stepping up its push for generic medicines in hospitals, urging healthcare providers to prescribe and stock low-cost alternatives to branded drugs.
AstraZeneca made a major move today with its experimental COPD drug tozorakimab, reporting that the treatment significantly reduced moderate to severe flare ups of chronic obstructive pulmonary disease (COPD) in two late stage Phase III trials.
Eli Lilly’s eczema drug Ebglyss (lebrikizumab) is making waves with new long term data showing strong, lasting results for people with moderate to severe atopic dermatitis.
Over two transformative days, global and Indian thought leaders will explore the evolution of Good Manufacturing Practices toward a culture of quality maturity, transparency, and patient trust. Discussions will span audit readiness
Biocon Limited has named Shreehas Tambe as its new chief executive officer and managing director, effective April 1, 2026.
Chennai-based MGM Healthcare has set up what it says is the world’s largest intestinal rehabilitation programme and intestinal transplant programme in just three years, marking a significant step forward for advanced healthcare in India.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")